|

nab-paclitaxel combined with carboplatin Clinical Trials

1 actively recruiting trial

Also known as: paclitaxel combined with carboplatin

Pipeline

Phase 3: 1

Top Sponsors

  • Women's Hospital School Of Medicine Zhejiang University1

Indications

  • Primary Peritoneal Carcinoma Stage IV1
  • Primary Peritoneal Carcinoma Stage III1
  • Fallopian Tube Carcinoma Stage IV1
  • Fallopian Tube Carcinoma Stage III1
  • Epithelial Ovarian Carcinoma Stage IV1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.